Curcumin treatment suppressed the expression level of proteins viz., TLR-4, MyD88, and NF-κB in the inflamed tissue and suggested that upstream signaling molecules TLR-4 and MyD88 are the potential therapeutic target in IBD [86]. The gene discussed is NFKB1; the disease is inflammatory bowel disease.